November 25, 2022
Professor Imoto received the NPB Distinguished Service Award and the 2022 J-League Distinguished Service Award for his past advice to the NPB and J-League on COVID-19 infection control.
The November issue of Experimental Medicine published a collection of commentary papers that I planned with Prof. Uematsu titled "Is Phage Therapy a Chief Card against Multidrug-Resistant Bacteria?" with five papers; (1) Introduction (2) Metagenome analysis and next-generation phage therapy (3) Modified phage therapy (4) Development of gene-targeted CRISPR-Cas-loaded antimicrobial phage and (5) Practical application of phage therapy based on clinical trials. Please take a look.
The Hitachi Academic System Study Group, of which Prof. Imoto serves as vice president, is scheduled to hold its 47th meeting on Monday, September 26, at 1:30 p.m. The theme is "What Data Utilization Infrastructure is Necessary for Data Strategy? The meeting will be held online and there is no charge for participation. Please join us.
Contributed an article titled "Prospects for Stratified Medicine from Metagenomic Analysis" to "Autoimmune Diseases: Toward a New Era of Stratification" in the Experimental Medicine supplement issue. The article describes the development of novel therapies using information from the intestinal microbiota metagenome. Co-authored with Prof. Uematsu and Associate Prof. Fujimoto.
The second story of "MARCO x Kao Special Conversations" with Mr. Fujii of Kao Corporation, entitled "Bringing the Results of the Tokyo Olympics to the Field of Professional Sports. Toward the Resumption of Social Activities" is now available.
As part of the "Project for Promotion of Human Resource Development on Whole Genome Analysis of Cancer" commissioned by the Ministry of Health, Labour and Welfare, "Lectures on Genome Analysis of Cancer in Clinical Practice" will be held as in the previous year. Prof. Imoto is cooperating as the chairperson of the review committee. Associate Professor Katayama will also serve as a lecturer.
A dialogue (Part 1 of 2) with Kenkichi Fujii, General Manager, Research Strategy & Planning Department, Research & Development Division, Kao Corporation, is now available. In this interview, Prof. Imoto and Mr. Fujii talk about "What We Have Learned from the Infection Risk Assessment of the Tokyo Olympics Toward Realization of a Safe Society and Lifestyles".
A conversation with Kenkichi Fujii, General Manager of Kao Corporation's Research and Development Division, regarding cooperation in infection control measures for the Tokyo Olympics and other events, is now available.
Associate Professor Yao-zhong Zhang will present a paper "On the application of BERT models for nanopore methylation detection" at IEEE International Conference on Bioinformatics and Biomedicine. This is deep learning development to identify structural variants from long read sequencing data.
A doctor course student, Yunjie Liu, presents his paper "Discovering microbe functionality in human disease with a gene-ontology-aware model" at the international conference Biological ontologies and knowledge bases (BiOK). This is a research on the development of metagenomic data analysis methods that are attracting attention around the world.
Prof. Imoto will give a talk at the 50th Annual Meeting of the Japanese Society for Immunology Symposium (System immunology approach for immune regulation research). The title of his talk is "Metagenome analysis leads a paradigm shift in health/medical care". He will discuss the contents of papers published in Gastroenterology and Cell Host Microbe this year and last year.
The full text of the discussion between Prof. Imoto and IBM CTO Morimoto at Day 4 of IBM Think Summit Japan (10/5-10/8)
"Cutting-edge Technology for the Future" is now available. We are talking about future technologies in COVID-19,
cancer genomic medicine, and gut microbiome research.
MARCO (MAss gathering Risk COntrol and Communication) (Representative: Seiya Imoto), a volunteer research group for risk control and communication in large-scale gatherings, received the 2021 Good Practice Award from the Society for Risk Analysis, Japan.
The website of the 2016 Survey of Working Styles of Doctors (Survey of 100,000 Doctors, Principal Investigator: Imoto) was suspended due to the end of the survey, but due to the application of work style reforms for doctors in 2024. Reopened. Please note that the URL has changed.
Project Associate Professor Zhang has published a new deep learning model based on the deep segmentation model, UNet, for identifying single nucleotide level breakpoints of structural variants from nanopore sequencing data. The paper has been published in PLoS Computational Biology.
Japan COVID-19 Task Force, in which Professor Imoto participates,
discovers a promising candidate for a factor contributing to the severity of new coronavirus infections
in the Japanese population.
Our research paper, the first in the world to solve the mystery of fecal microbiota transplantation, was selected for the cover of Gastroenterology (Vol. 160, Issue 6), the premier journal of gastroenterology.
Prof. Imoto contributed to the March issue of the Journal of the Japanese Society of Internal Medicine with an article titled "Application of Artificial Intelligence (AI) to Clinical and Genomic Medicine".